Table 1.
Genetic alteration | Prevalance in Asian patients (%) |
Frequency in patients from Western countries (%) |
---|---|---|
ERG-TMPRSS2 fusion | 8–21 [19,21–23] | 50–70 [17] |
PTEN inactivation | 34 [24] | 70 [24,30] |
CTAGE-KHDRBS3 fusion | 37 [21] | Unkown |
USP9Y-TTTY15 fusion | 35 [21] | Unkown |
KRAS mutations | 7–17 [25–29] | Up to 3 [25,31] |
BRAF copy number gain | 29 [28] | 9 [28] |